Related Experiment Video

Updated: Aug 3, 2025

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

7.6K

The Molecular Basis for the Environmental Promotion of Neurodegenerative Disease

Stephen Bondy1

  • 1Department of Environmental and Occupational Health, University of California, Irvine, CA 92617, USA.

International Journal of Molecular Sciences
|April 13, 2023
PubMed

Insights

Most neurodegenerative diseases are not primarily caused by genetics. Environmental factors and lifestyle choices play a more significant role in their development.

Area of Science:

  • Neuroscience
  • Genetics
  • Epidemiology

Background:

  • Neurodegenerative diseases represent a significant global health challenge.
  • While genetics plays a role, most cases have a minor genetic component.
  • Environmental and lifestyle factors are increasingly recognized as critical contributors.

Discussion:

  • The interplay between genetic predisposition and environmental triggers is complex.
  • Understanding non-genetic factors is crucial for effective prevention strategies.
  • Research is shifting towards identifying modifiable risk factors.

Key Insights:

  • Genetic factors account for a small proportion of neurodegenerative disease risk.
  • Environmental exposures and lifestyle choices are major determinants.
  • This highlights the potential for public health interventions.

Outlook:

  • Future research should focus on elucidating specific environmental impacts.
  • Developing targeted interventions based on non-genetic risk factors is essential.
  • This paradigm shift may lead to novel therapeutic and preventative approaches.

More Related Videos

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry12:31

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Published on: December 8, 2015

15.1K
A Protocol for Housing Mice in an Enriched Environment09:30

A Protocol for Housing Mice in an Enriched Environment

Published on: June 8, 2015

18.4K

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
628
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
639
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
551
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K